KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Other Accumulated Expenses (2016 - 2025)

Charles River Laboratories International (CRL) has 16 years of Other Accumulated Expenses data on record, last reported at $222.2 million in Q4 2025.

  • For Q4 2025, Other Accumulated Expenses rose 14.51% year-over-year to $222.2 million; the TTM value through Dec 2025 reached $222.2 million, up 14.51%, while the annual FY2025 figure was $222.2 million, 14.51% up from the prior year.
  • Other Accumulated Expenses reached $222.2 million in Q4 2025 per CRL's latest filing, up from $216.0 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $222.2 million in Q4 2025 and bottomed at $164.0 million in Q3 2021.
  • Average Other Accumulated Expenses over 5 years is $201.1 million, with a median of $203.9 million recorded in 2022.
  • Peak YoY movement for Other Accumulated Expenses: decreased 4.53% in 2024, then grew 14.51% in 2025.
  • A 5-year view of Other Accumulated Expenses shows it stood at $164.0 million in 2021, then rose by 24.74% to $204.6 million in 2022, then fell by 0.67% to $203.2 million in 2023, then fell by 4.53% to $194.0 million in 2024, then increased by 14.51% to $222.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $222.2 million in Q4 2025, $216.0 million in Q3 2025, and $207.2 million in Q2 2025.